Lv11
30 积分 2022-03-09 加入
MetastaticHER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
4小时前
待确认
Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review
4个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
4个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
4个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
5个月前
已完结
Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy
5个月前
已完结
The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders
5个月前
已完结
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
7个月前
已完结
Prevalence and Therapeutic Targeting of High Level ERBB2 Amplification in Non-Small Cell Lung Cancer
7个月前
已完结
A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
9个月前
已完结
皖公网安备34019202002308
